KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Return on Invested Capital: 2010-2025

Historic Return on Invested Capital for Alnylam Pharmaceuticals (ALNY) over the last 2 years, with Jun 2025 value amounting to -0.50%.

  • Alnylam Pharmaceuticals' Return on Invested Capital was N/A to -0.50% in Q2 2025 from the same period last year, while for Jun 2025 it was -0.50%, marking a year-over-year change of. This contributed to the annual value of 4.36% for FY2024, which is N/A change from last year.
  • Per Alnylam Pharmaceuticals' latest filing, its Return on Invested Capital stood at -0.50% for Q2 2025, which was down 12.80% from -0.44% recorded in Q1 2025.
  • Over the past 5 years, Alnylam Pharmaceuticals' Return on Invested Capital peaked at -0.44% during Q1 2025, and registered a low of -1.35% during Q4 2024.
  • Over the past 2 years, Alnylam Pharmaceuticals' median Return on Invested Capital value was -0.50% (recorded in 2025), while the average stood at -0.76%.